What Hedge-Fund Managers are Reading This Morning
May 17th, 2008 | By Rob Fannon | Category: Stock Market InvestingLast May, shares of Regeneron Pharmaceuticals (REGN), a billion-dollar biotech, slid 35% in just 30 days. The company had no press releases, no earnings reports, nothing.
